UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

An Open-Label Dose Escalation Study to Evaluate the Safety of Administration of Nonviral Stromal Cell-Derived Factor-1 Plasmid to Treat Symptomatic Ischemic Heart Failure

Circulation research, 2013-03, Vol.112 (5), p.816-825

2013

Volltextzugriff (PDF)

Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: Results of the HGF-0205 trial

Journal of vascular surgery, 2010-12, Vol.52 (6), p.1525-1530

2010

Volltextzugriff (PDF)

Renal Denervation of Accessory Renal Arteries

JACC. Cardiovascular interventions, 2014-03, Vol.7 (3), p.340-341

Mendelsohn, Farrell O., MD

2014

Volltextzugriff (PDF)

Primary renal artery stenting: Characteristics and outcomes after 363 procedures

The American heart journal, 2001-08, Vol.142 (2), p.314-323

2001

Volltextzugriff (PDF)

Micro-anatomy of the renal sympathetic nervous system: A human postmortem histologic study

Clinical anatomy (New York, N.Y.), 2012-07, Vol.25 (5), p.628-633

2012

Volltextzugriff (PDF)

Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial

European heart journal, 2015-09, Vol.36 (33), p.2228-2238

2015

Volltextzugriff (PDF)

Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure

Journal of the American College of Cardiology, 2023-03, Vol.81 (9), p.849-863

2023

Volltextzugriff (PDF)

Does complete renal denervation translate into superior clinical outcomes? Lessons learned from denervation of accessory renal arteries

Clinical research in cardiology, 2014-09, Vol.103 (9), p.681-683

Mendelsohn, Farrell O.

2014

Volltextzugriff (PDF)

Adventitial Delivery of an Allogeneic Bone Marrow–Derived Adherent Stem Cell in Acute Myocardial Infarction: Phase I Clinical Study

Circulation research, 2012-01, Vol.110 (2), p.304-311

2012

Volltextzugriff (PDF)

Regional angiogenesis with Vascular Endothelial growth factor in peripheral arterial disease: A phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication

Circulation (New York, N.Y.), 2003-10, Vol.108 (16), p.1933-1938

2003

Volltextzugriff (PDF)

Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine model

Journal of hypertension, 2014-08, Vol.32 (8), p.1678-1692

2014

Volltextzugriff (PDF)

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

The Lancet (British edition), 2002-06, Vol.359 (9323), p.2053-2058

2002

Volltextzugriff (PDF)

Acute hemodynamic changes during carotid artery stenting

The American journal of cardiology, 1998-11, Vol.82 (9), p.1077-1081

1998

Volltextzugriff (PDF)

Sex differences in coronary artery size assessed by intravascular ultrasound

The American heart journal, 2000-04, Vol.139 (4), p.649-652

2000

Volltextzugriff (PDF)

SDF-1 Plasmid Attenuates Adverse Remodeling in Ischemic Heart Failure Patients in a Randomized Phase II Trial

Journal of cardiac failure, 2014-08, Vol.20 (8), p.S9-S10

2014

Volltextzugriff (PDF)

Regional angiogenesis with vascular endothelial growth factor (VEGF) in peripheral arterial disease: Design of the RAVE trial

The American heart journal, 2003-06, Vol.145 (6), p.1114-1118

2003

Volltextzugriff (PDF)

Re-Establishment of SDF-1 Expression Through Non-Viral Gene Therapy Improves Clinical Parameters Through 12 Months in Patients With Ischemic Class III Heart Failure

Journal of cardiac failure, 2012-08, Vol.18 (8), p.S59-S60

2012

Volltextzugriff (PDF)

Hyperperfusion syndrome following carotid artery stenting: the largest single-operator series to date

The Journal of invasive cardiology, 2009-01, Vol.21 (1), p.27-30

2009

Volltextzugriff (PDF)

Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease

Human gene therapy, 2004-06, Vol.15 (6), p.619-624

2004

Volltextzugriff (PDF)

Intravascular ultrasonic analysis of plaque characteristics associated with coronary artery remodeling

The American journal of cardiology, 1999-07, Vol.84 (1), p.37-40

1999

Volltextzugriff (PDF)

Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial

The American journal of cardiology, 2001-07, Vol.88 (2), p.192-195

2001

Volltextzugriff (PDF)

Abstract 19419: A Phase IIa Randomized Double-Blind, Placebo Controlled Study to Evaluate Plasmid Stromal Cell-Derived Factor-1 for Treatment of Critical Limb Ischemia - The STOP-CLI Trial

Circulation (New York, N.Y.), 2014-11, Vol.130 (suppl_2)

2014

Volltextzugriff (PDF)

Implications of smoking status on the response to therapeutic angiogenesis in peripheral artery disease: findings from the therapeutic angiogenesis with FGF-2 for intermittent claudication (TRAFFIC) trial

Journal of the American College of Cardiology, 2002-03, Vol.39, p.207-207

2002

Volltextzugriff (PDF)

In vivo assessment by intravascular ultrasound of enlargement in saphenous vein bypass grafts

The American journal of cardiology, 1995-11, Vol.76 (14), p.1066-1069

1995

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

An Open-Label Dose Escalation Study to Evaluate the Safety of Administration of Nonviral Stromal Cell-Derived Factor-1 Plasmid to Treat Symptomatic Ischemic Heart Failure

Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: Results of the HGF-0205 trial

A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: Design of the RENEW study

Renal Denervation of Accessory Renal Arteries

Primary renal artery stenting: Characteristics and outcomes after 363 procedures

Micro-anatomy of the renal sympathetic nervous system: A human postmortem histologic study

Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial

Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure

Does complete renal denervation translate into superior clinical outcomes? Lessons learned from denervation of accessory renal arteries

Adventitial Delivery of an Allogeneic Bone Marrow–Derived Adherent Stem Cell in Acute Myocardial Infarction: Phase I Clinical Study

Regional angiogenesis with Vascular Endothelial growth factor in peripheral arterial disease: A phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication

Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine model

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

Acute hemodynamic changes during carotid artery stenting

Sex differences in coronary artery size assessed by intravascular ultrasound

SDF-1 Plasmid Attenuates Adverse Remodeling in Ischemic Heart Failure Patients in a Randomized Phase II Trial

Regional angiogenesis with vascular endothelial growth factor (VEGF) in peripheral arterial disease: Design of the RAVE trial

Re-Establishment of SDF-1 Expression Through Non-Viral Gene Therapy Improves Clinical Parameters Through 12 Months in Patients With Ischemic Class III Heart Failure

Hyperperfusion syndrome following carotid artery stenting: the largest single-operator series to date

Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease

Intravascular ultrasonic analysis of plaque characteristics associated with coronary artery remodeling

Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial

Abstract 19419: A Phase IIa Randomized Double-Blind, Placebo Controlled Study to Evaluate Plasmid Stromal Cell-Derived Factor-1 for Treatment of Critical Limb Ischemia - The STOP-CLI Trial

Implications of smoking status on the response to therapeutic angiogenesis in peripheral artery disease: findings from the therapeutic angiogenesis with FGF-2 for intermittent claudication (TRAFFIC) trial

In vivo assessment by intravascular ultrasound of enlargement in saphenous vein bypass grafts

Suchergebnisse filtern